Xenotransplants. The next frontier for organ replacement;Xenotrasplantes. La próxima frontera en el reemplazo de órganos

Medicina

Volumn 63, Issue 4, 2003, Pages 344-346

  Argibay, Pablo ^a  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; COMPLEMENT; CORTICOTROPIN RELEASING FACTOR;

ARGENTINA; EDITORIAL; HEART TRANSPLANTATION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INTESTINE TRANSPLANTATION; LUNG TRANSPLANTATION; NONHUMAN; ORGAN DONOR; PANCREAS TRANSPLANTATION; PATIENT CARE; RETROVIRUS; SURGICAL TECHNIQUE; TREATMENT OUTCOME; XENOTRANSPLANTATION; ZOONOSIS;

ANIMALS; ENDOGENOUS RETROVIRUSES; HUMANS; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0141762701     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (17)

1. Thomas E. Starzl. The puzzle people: memoirs of a transplant surgeon. Philadelphia:University of Pittsburgh Press, 1992, p. 3.
2. Siminoff LA, Gordon N, Hewlett J, Arnold RM. Factors influencing families' consent for donation of solid organs for transplantation. JAMA 2001; 4; 286: 71-7.
3. Cantarovich F. Improvement in organ shortage through education. Transplantation 2002; 73: 1844-6.
4. Castagna R, Pose A, Izrastzoff T, Albornoz M, Valdez P. Procuración de órganos y tejidos: Dificultades para la implementación de la misma. Rev Nefrol Dial Traspl 2001; 53: 3-19.
5. Dooldeniya MD, Warrens AN. Xenotransplantation: where are we today? J R Soc Med 2003; 96: 111-7.
6. Dorling A, Riesbeck K, Warrens A, Lechler R. Clinical xenotransplantation of solid organs. Lancet 1997; 349: 867-71.
7. Sandrin MS, McKenzie IF. Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies Immunol Rev 1994; 141: 169-90.
8. Dalmasso AP, Platt JL, Bach FH. Reaction of comple-ment with endothelial cells in a model of xenotransplan-tation. Clin Exp Immunol 1991; 86 (Suppl 1): 31-5.
9. Schuurman HJ, Pino-Chavez G, Phillips MJ, Thomas L, White DJ, Cozzi E. Incidence of hyperacute rejection in pig-to-primate transplantation using organs from hDAF-transgenic donors. Transplantation 2002; 73: 1146-51.
10. Bach FH, Winkler H, Ferran C, Hancock WW, Robson SC. Delayed xenograft rejection. Immunol Today 1996; 17: 379-84.
11. Blusch JH, Patience C, Martin U. Pig endogenous retroviruses and xenotransplantation. Xenotransplantation 2002; 9: 242-51.
12. Pérez C, Wylie D, López O. Variable kappa gene usage in swine antibodies. Medicina (Buenos Aires) 2003, 63: 305-8.
13. Herring C, Cunningham DA, Whittam AJ, Fernandez-Suarez XM, Langford GA. Monitoring xenotransplant recipients for infection by PERV. Clin Biochem 2001; 34: 23-7.
14. Chmielewicz B, Goltz M, Franz T, et al. A novel porcine gammaherpesvirus. Virology 2003; 308: 317-29.
15. Millis JM, Cronin DC, Johnson R, et al. Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: system modifications and clinical impact. Transplantation 2002; 74: 1735-46.
16. Korsgren O, Buhler LH, Groth CG. Toward clinical trials of islet xenotransplantation. Xenotransplantation 2003; 10: 289-92.
17. Borlongan CV, Sanberg PR. Neural transplantation for treatment of Parkinson's disease. Drug Discov Today 2002; 7: 674-82.